Some type of behavior therapy is typically involved for long-term success, teamwork, periodic evaluations, etc
Semaglutide, Tirzepatide, and GLP-1 Options Several medications are now discussed under the GLP-1 weight loss category, but they are not all identical
Make sure to let your health care provider know if you have any negative side effects as you increase the dose
Sobo approaches medical weight loss as long-term metabolic care
Side effect rates for GLP-1 agonists in studies hit as high as 87% in treatment arms compared to 79% in placebo, proving these are common but not retatrutide-specific
The trajectory of weight regain is typically faster than the time it takes people to lose the weight in the first place, according to Miras